Dopaminergic medications used in the treatment of patients with Parkinson's disease are
associated with motor and non-motor behavioural side-effects, such as dyskinesias and …

Non-substance addictive behaviors may involve repetitive rewarding behaviors including
gambling, gaming, sexual activities, internet-use, and buying-shop**. In addictions, there …

Impulse control and related disorders (ICDs-RD) encompasses a heterogeneous group of
disorders that involve pleasurable behaviors performed repetitively, excessively, and …

Molecular imaging has proven to be a powerful tool for investigation of parkinsonian
disorders. One current challenge is to identify biomarkers of early changes that may predict …

Problematic gambling has been suggested to be a possible consequence of dopaminergic
medications used mainly in neurological conditions, ie pramipexole and ropinirole, and …

Nanomaterials offer tremendous potential for cancer imaging and therapy due to their
unique intrinsic characteristics. Combining imaging and therapeutic agents in one …

Impulsive-compulsive behaviours like pathological gambling or hypersexuality are a
frequent side effect of dopamine replacement therapy in patients with Parkinson's disease …

Background: In Parkinson's disease (PD), impulse control disorders (ICDs) develop as side-
effect of dopaminergic replacement therapy (DRT). Cognitive, affective, and motivational …

Addictions involve a spectrum of behaviors that encompass features of impulsivity and
compulsivity, herein referred to as impulsive-compulsive spectrum disorders (ICSDs). The …

The nigrostriatal and mesocorticolimbic dopamine networks regulate reward-driven
behavior. Regional alterations to mesolimbic dopamine D2/3 receptor expression are …